IHS Health, LLC

Kissimmee, Florida 34741

2 studies enrolling now · 18 studies all time

What they study most

Adenoma, Colitis, Ulcerative, Colon Cancer, Colon Diseases, Colon Lesion, Colon Neoplasm, Colon Polyp, Colorectal Cancer, Crohn Disease, Crohn's Disease, Crohn's Disease (CD), Eosinophilic Esophagitis

Studies at this site

• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) — Recruiting now
• Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening — Recruiting now
• Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories — Completed
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — Enrolling by invitation
• Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years — Running, not enrolling
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• Prevention of Colorectal Cancer Through Multiomics Blood Testing — Completed
• A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease — Stopped early
• 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) — Completed
• A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) — Completed
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Stopped early
• Efficacy and Safety of Oral BT-11 in Ulcerative Colitis — Completed
• Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis — Completed